(Date:5/16/2008)...ices for Frail Seniors and People With,Disabilitie.../ -- Thousands of,homecare workers across the stat...posed cuts to hours of service, wages and benefits...erable workers and the,people they serve deeper in...ces for seniors and people with disabilities from ...
(Date:5/16/2008)... more unemployed politicians - and economists, O...hough nearly all,voters place health care at the t...g federal budgetary crunch means none of the healt...ential candidates is likely to become,law anytime ... Frist., Jousting with Princeton University Healt...
(Date:5/16/2008)...ese students learn the lesson of helping others ...e, NANJING, China, May 16 /PRNewswire/ -- In the ...ven the youngest members of China are,looking for ...ll around the,country, schools are running donatio...hool,s principal, Ms. Zhang Lijun, the 190-student...
(Date:5/16/2008)...swire-FirstCall/ -- CryoCor, Inc. (Nasdaq:,CRYO), ...of cardiac,arrhythmias, announced today that on Ma...tock filed a complaint in the Superior Court of th... as defendants each member of the,Board of Directo...ration.,The complaint is styled Secondido, et al. ...
Breaking Medicine News(10 mins):Health News:Homecare Workers Outraged by Proposed Cuts, Wage Reductions 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 2Health News:Former Senate Majority Leader, Princeton Economist Joust on Future of Health Care 3Health News:Chinese Preschoolers Participate in Fund Drive to Help the Victims of Sichuan Quake 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 2Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 3Health News:CryoCor, Inc. Subject of Lawsuit Relating to Tender Offer and Merger 4(Date:5/15/2008)...hase II Data Presented at ASCO Showed Acceptable T...e of Grade 3 and 4 Neuropathy, WOODCLIFF LAKE, N....motherapeutic agent eribulin mesylate (E7389) demo...on of women with locally advanced or metastatic,br...r Phase II clinical,trial. The study also suggests...
(Date:5/15/2008)... - Unprecedented amount of research reflects dep...rs worldwide to develop new treatments for ...y session to highlight impact of Zometa(R), the le...nts with early-stage breast cancer, - Four oral s...ontinuous, inhibitor of mTOR, including first resu...
(Date:5/15/2008)...od pressure reductions demonstrated in Blacks, His...tes and Obese Individuals, PARSIPPANY, N.J., May ... today that data presented at the American Society... Meeting (ASH 2008) in New,Orleans demonstrated th...ine and olmesartan medoxomil) safely and effective...
(Date:5/15/2008)...Excellent results obtained with a newly cleared de... plaques of interest that are associated with ... BURLINGTON, Mass., May 15 /- InfraRe...nt Hospital in Royal Oak, Mich., have,successfully...a patient,undergoing a cardiac catheterization. Th...
Breaking Medicine Technology:Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 2Eribulin Mesylate Demonstrated Anti-Tumor Activity in Heavily Pretreated Patients with Advanced Breast Cancer 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 2Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 3Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 4Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 5Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 6Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 7Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 8Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 9Strength and Innovation of Novartis Oncology Products and Pipeline With Potential to Improve Patient Treatment Demonstrated by More Than 170 Abstracts at ASCO Annual Meeting 10Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 2Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 3Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 4Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 5Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 6Azor(TM) Reduces Blood Pressure in Difficult to Treat Special Populations 7First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 2First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 3First Use in a Patient of The InfraReDx LipiScan(TM) Coronary Imaging System 4Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 1Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 2Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 3Synvista Therapeutics Announces Initiation of Phase 2 Study With Alagebrium for Chronic Heart Failure 827 4The Ultimate Stress Reliever SpaCapsule 28R 29 the Capsule that Takes You on a Rejuvenating Journey to the Spa Retains TransMedia Group for Soothin 6056 1The Ultimate Stress Reliever SpaCapsule 28R 29 the Capsule that Takes You on a Rejuvenating Journey to the Spa Retains TransMedia Group for Soothin 6056 2Fuwei Films Announces Third Quarter 2007 Financial Results 6052 1Fuwei Films Announces Third Quarter 2007 Financial Results 6052 2Fuwei Films Announces Third Quarter 2007 Financial Results 6052 3Fuwei Films Announces Third Quarter 2007 Financial Results 6052 4Fuwei Films Announces Third Quarter 2007 Financial Results 6052 5Fuwei Films Announces Third Quarter 2007 Financial Results 6052 6World Diabetes Day Lights Up the Skyline 6048 1World Diabetes Day Lights Up the Skyline 6048 2World Diabetes Day Lights Up the Skyline 6048 3...at the Movement Disorder Society,s 11th,Internatio..., June 08, 2007 /PRNewswire-FirstCall/ -- New,info...ts) for the,treatment of Parkinson,s disease (PD) ...ciety,s congress in Istanbul, Turkey.,Once-daily A...he,treatment of the signs and symptoms of PD, both...
...xas, June 08, 2007 /PRNewswire-FirstCall/ --,Lexic...cation of,new findings from a joint research proje...hiladelphia, PA. Together with David L.,Wiest, Ph....d,surprising role for ribosomal protein L22 (Rpl22...ngs have been published in,the June issue of the j...
Other Medicine Technology:International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 2International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 3International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 4International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 5International Movement Disorder Specialists Receive New Information,About the Use of Once-Daily Azilect in the Treatment of Parkinson's,Disease 6Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 2Lexicon Pharmaceuticals and Fox Chase Publish Findings on Immune,Deficiency 3Designed as an excellent form of primary suspension
...enefits of controlled compression and cold, the Ca... pain. The anatomically designed cuff provides com...yo/Cuffs can be ordered as a single cuff, or with ... disk). The Cooler is available separately and can...
Bird and Cronin, Inc. is a leading manufacturer of Patient Footwear, Orthopedic Softgoods, and Specialty Patient Care Products. Our products are of the highest quality and available in the USA and In
...Splint provides effective long-term stabilization ...le radial and palmar stays immobilize wrist and th...caphoid and soft tissue injuries. D-ring contact c...ior fit and unparalleled comfort. Padding thicknes...
Medicine Products: